Detailansicht

Wissensnetz

Person

Elham Kayvanpour (1984-)

Ärztin

Name	Elham Kayvanpour
Zeit	1984- (Lebensdaten)
Ort	Heidelberg (Wirkungsort) Teheran (Geburtsort) Deutschland Iran
Geschlecht	weiblich
Akademischer Grad bzw. Titel	PD Dr. med.
Beruf	Ärztin (charakteristischer Beruf)
Beziehung	Klinikum Heidelberg
Weitere Angaben	Diss. Medizinische Fakultät Heidelberg der Ruprecht-Karls-Universität; Assistenzärztin, Innere Medizin III: Kardiologie, Angiologie und Pneumologie, Medizinische Klinik, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	1033468983
Datensatz-ID	1033468983
Beteiligt an alle anzeigen Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathies Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information Genotype complements the phenotype: identification of the pathogenicity of an LMNA splice variant by nanopore long-read sequencing in a large DCM family Identification of SCN5a p.C335R variant in a large family with dilated cardiomyopathy and conduction disease VARS2 depletion leads to activation of the integrated stress response and disruptions in mitochondrial fatty acid oxidation NIMA-related kinase 9 regulates the phosphorylation of the essential myosin light chain in the heart Controlling my genome with my smartphone: first clinical experiences of the PROMISE system Multi-omics assessment of dilated cardiomyopathy using non-negative matrix factorization Controlling my genome with my smartphone: first clinical experiences of the PROMISE system Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy Marathon-Induced Cardiac Strain as Model for the Evaluation of Diagnostic microRNAs for Acute Myocardial Infarction Postcardiac injury syndrome after cardiac implantable electronic device implantation Epigenetic Regulation of Alternative mRNA Splicing in Dilated Cardiomyopathy Clinical and genetic insights into non-compaction: a meta-analysis and systematic review on 7598 individuals Genomic structural variations lead to dysregulation of important coding and non‐coding RNA species in dilated cardiomyopathy Genomic structural variations lead to dysregulation of important coding and non-coding RNA species in dilated cardiomyopathy Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals The prognostic value of right ventricular long axis strain in non-ischaemic dilated cardiomyopathies using standard cardiac magnetic resonance imaging Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals Alterations in cardiac DNA methylation in human dilated cardiomyopathy Verlust von four-and-a-half LIM domains protein 1 (FHL1) führt zur myofibrillären Myopathie im Zebrafisch

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Elham Kayvanpour (1984-)

Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathies

Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information

Genotype complements the phenotype: identification of the pathogenicity of an LMNA splice variant by nanopore long-read sequencing in a large DCM family

Identification of SCN5a p.C335R variant in a large family with dilated cardiomyopathy and conduction disease

VARS2 depletion leads to activation of the integrated stress response and disruptions in mitochondrial fatty acid oxidation

NIMA-related kinase 9 regulates the phosphorylation of the essential myosin light chain in the heart

Controlling my genome with my smartphone: first clinical experiences of the PROMISE system

Multi-omics assessment of dilated cardiomyopathy using non-negative matrix factorization

Controlling my genome with my smartphone: first clinical experiences of the PROMISE system

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy

Marathon-Induced Cardiac Strain as Model for the Evaluation of Diagnostic microRNAs for Acute Myocardial Infarction

Postcardiac injury syndrome after cardiac implantable electronic device implantation

Epigenetic Regulation of Alternative mRNA Splicing in Dilated Cardiomyopathy

Clinical and genetic insights into non-compaction: a meta-analysis and systematic review on 7598 individuals

Genomic structural variations lead to dysregulation of important coding and non‐coding RNA species in dilated cardiomyopathy

Genomic structural variations lead to dysregulation of important coding and non-coding RNA species in dilated cardiomyopathy

Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals

The prognostic value of right ventricular long axis strain in non-ischaemic dilated cardiomyopathies using standard cardiac magnetic resonance imaging

Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals

Alterations in cardiac DNA methylation in human dilated cardiomyopathy

Verlust von four-and-a-half LIM domains protein 1 (FHL1) führt zur myofibrillären Myopathie im Zebrafisch